Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

Hard to know for sure. But remember that stage two started enrolling full force in late 2014/early 2015. majority of patients were enrolled in 2015 (we know this from 8-k filing from halozyme in 2015 projecting to complete enrollment In 2nd half of 2015).

This projection was false but one could reasonably conclude that the numbers enrolled in Jan and Feb of this year must been quite small. If stage 1 PFS is any indication and considering multiple pt anecdotes, the number of patients left without progression is likely very small (far better than controll pts but nonetheless small). I wouldn't be surprised if an event/progression in just one pt now would mature the data any day now.